Clinical Trials Directory

Trials / Terminated

TerminatedNCT04786808

Risk Factors for COVID-19 Mortality

Risk Factors for COVID-19 Mortality: a Prospective Observational Study

Status
Terminated
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Teodoro Marcianò · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

COVID-19 pandemic has deeply burdened hospitals all over the world. A two-stage disease has been hypothesized due to quick worsening of clinical status after 7-10 days from the beginning of first symptoms, generally flu-like symptoms. Predicting clinical worsening could help to address major efforts towards higher risk patients. During the last year most observational studies, generally retrospective, has been conducted, identifying some risk factors such as age, obesity, male gender, cardiovascular disease, COPD, diabetes etc. The study goal is to collect systematically a variegate amount of clinical, biometric, laboratory and radiological data from patients admitted to the Emergency Medicine Ward of Piacenza Hospital (Italy), in order to prospectively analyze what characteristics are associated to higher risk of mortality.

Conditions

Timeline

Start date
2021-01-15
Primary completion
2021-11-07
Completion
2021-11-07
First posted
2021-03-08
Last updated
2021-11-15

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04786808. Inclusion in this directory is not an endorsement.

Risk Factors for COVID-19 Mortality (NCT04786808) · Clinical Trials Directory